Healthy high growth potential
Résultats
7
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
7 entreprises
| Entreprise | Dernier prix | 7D Retour | Retour 1 an | Capitalisation boursière | Cible des analystes | Évaluation | Croissance | Rendement des dividendes | L'industrie | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CLR | €22.20 | -0.9% | 395.5% | €400.4m | €21.15 | 28.3 | 82.8% | n/a | Capital Goods | ||
EBROM | €9.95 | -0.5% | 18.2% | €481.6m | €13.03 | 1.2 | 74.9% | n/a | Automobiles | ||
BYTE | €4.00 | -0.5% | -33.3% | €119.9m | n/a | 553.7 | 60.9% | n/a | Consumer Services | ||
ART | €29.10 | 1.0% | 125.6% | €1.7b | €34.25 | 29.9 | 22.8% | 0.6% | Capital Goods | ||
PHM | €83.60 | 1.8% | 4.7% | €1.4b | €104.39 | 25.8 | 37.2% | 1.2% | Pharmaceuticals & Biotech | ||
LIB | €3.03 | -0.3% | -20.7% | €64.4m | n/a | 16.1 | 34.1% | 2.0% | Real Estate Management and Development | ||
FACE | €1.84 | 0.5% | -31.6% | €48.7m | €3.70 | 152.8 | 54.2% | n/a | Software |
Page 1 of 1